| Name | Title | Contact Details |
|---|
The Exploratorium is a public learning laboratory located in San Francisco, California. Founded in 1969 by physicist Frank Oppenheimer, it focuses on transforming education through interactive experiences that blend science, art, and human perception. The institution serves as a hybrid museum, research lab, and educational hub, promoting inquiry-based exploration and encouraging visitors to ask questions and understand the world around them. The Exploratorium features hundreds of interactive exhibits covering a wide range of topics, all designed and built in-house. It offers educational programs that include community engagement initiatives, global collaborations, and professional development for educators. The organization also provides extensive digital content, including virtual exhibits and educational resources, attracting millions of visitors annually. Public events such as film screenings and workshops further enhance its outreach, making science accessible to diverse audiences.
Barton and Cooney is a Burlington, NJ-based company in the Business Services sector.
Old Cabot Automtve Neck Ties is a Beverly, MA-based company in the Business Services sector.
Genesis Systems Consulting is a Miami, FL-based company in the Business Services sector.
Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.